Mutagenesis of residues adjacent to transmembrane prolines alters D1 dopamine receptor binding and signal transduction

Molecular Pharmacology

Volumn 50, Issue 5, 1996, Pages 1338-1345

  Cho, William ^a   Taylor, Larry P ^a   Akil, Huda ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 1 RECEPTOR; PROLINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; DRUG RECEPTOR BINDING; GENETIC CONSERVATION; LIGAND BINDING; MENTAL DISEASE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

AMINO ACID SEQUENCE; ANIMALS; COS CELLS; DNA, COMPLEMENTARY; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROLINE; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, DOPAMINE D1; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0029829503     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Sibley, D. R., and F. J. Monsma, Jr. Molecular biology of dopamine receptors. Trends Pharmacol. Sci. Rev. 13:61-69 (1992).
2. 2 receptor. Eur. J. Pharmacol. 227:205-214 (1992).
3. Strader, C. D., I. S. Sigal, M. R. Candelore, E. Rands, W. S. Hill, and R. A. F. Dixon. Conserved aspartate residues 79 and 113 of the β-adrenergic receptor have different roles in receptor function. J. Biol. Chem. 263: 10267-10271 (1988).
4. 1 receptor affect ligand interactions and receptor activation. J. Biol. Chem. 267:17780-17786 (1992).
5. 2 receptors. J. Neurochem. 59:627-635 (1992).
6. Strader, C. D., M. R. Candelore, W. S. Hill, I. S. Sigal, and R. A. F. Dixon. Identification of two serine residues involved in agonist activation of the β-adrenergic receptor. J. Biol. Chem. 264:13572-13578 (1989).
7. s and increase agonist affinity. J. Biol. Chem. 262:16439-16443 (1987).
8. 2-adenergic receptor: localization of regions involved in G protein-receptor coupling. J. Biol. Chem. 263:15985-15992 (1988).
9. 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science (Wash. D. C.) 240:1310-1316 (1988).
10. Dixon, R. A. F., I. S. Sigal, and C. D. Strader. Structure-function analysis of the β-adrenergic receptor. Cold Spring Harbor Symp. Quant. Biol. 53:487-497 (1988).
11. s in response to muscarinic agonists. J. Biol. Chem. 265:6219-6224 (1990).
12. 2A-adrenergic receptor alter receptor-G protein coupling by distinct mechanisms. J. Biol. Chem. 266:11025-11029 (1991).
13. Trumpp-Kallmeyer, S., J. Hoflack, A. Bruinvels, and M. Hibert. Modeling of G-protein-coupled receptors: applications to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors. J. Med. Chem. 35:3448-3462 (1992).
14. Henderson, R., J. Baldwin, T. H. Ceska, F. Zemlin, E. Beckmann, and K. Downing. Model of the structure of bacteriorhodopsin based on high resolution electron cryomicroscopy. J. Mol. Biol. 213:899-929 (1990).
15. Schimmel, P. R., and P. J. Flory. Conformational energies and configurational statistics of copolypeptides containing L-proline. J. Mol. Biol. 34: 105-120 (1968).
16. MacArthur, M. W., and J. M. Thornton. Influence of proline residues on protein conformation. J. Mol. Biol. 218:397-412 (1991).
17. Williams, K. A., and C. M. Deber. Proline residues in transmembrane helices: structural or dynamic role? Biochemistry 30:8919-8923 (1991).
18. Deber, C. M., A. Polinsky, and M. Goodman. Conformational energy of proline-containing peptides in a non-polar environment, in Peptides 1990 (E. Giralt and D. Andreu, eds.). Vol. 10. ESCOM Science Publishers, Leiden, 485-487 (1991).
19. Brandi, C. J., and C. M. Deber. Hypothesis about the function of membrane-buried proline residues in transport proteins. Proc. Natl. Acad. Sci. USA 83:917-921 (1986).
20. Strader, C. D., I. S. Sigal, R. B. Register, M. R. Candelore, E. Rands, and R. A. F. Dixon. Identification of residues required for ligand binding to the β-adrenergic receptor. Proc. Natl. Acad. Sci. USA 84:4384-4388 (1987).
21. Brandts, J. F., H. R. Halvorson, and M. Brennan. Consideration of the possibility that the slow step in protein denaturation reactions is due to cis-trans isomerism of proline residues. Biochemistry 14:4953-4963 (1975).
22. Grathwohl. C., and K. Würtrich. Isomerization in oligopeptides. Biopolymers 20:2623-2633 (1981).
23. Chen, C., and H. Okayama. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752 (1987).
24. Munson, P. J., and D. Rodbard. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107:220-239 (1980).
25. 2 dopamine receptors. Nature (Lond.) 347: 76-79 (1990).
26. 1. Nature (Lond.) 350:614-619 (1991).
27. 2 receptors. Mol. Pharmacol. 43:755-761 (1993).
28. 2 dopamine receptor are important for binding and signal transduction. J. Neurochem. 66:2105-2115 (1995).
29. Lefkowitz, R. J., S. Cotecchia, P. Samana, and T. Costa. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci. 14:303-307 (1993).
30. 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc. Natl. Acad. Sci. USA 87:2896-2990 (1990).
31. 1B-adrenergic receptor by all amino acid substitutions at a single site. J. Biol. Chem. 267:1430-1433 (1992).
32. 2-adrenergic receptor: extending the ternary complex model. J. Biol. Chem. 268:4625-4636 (1993).
33. 2-adrenergic receptor. J. Biol. Chem. 268:16483-16487 (1993).
34. Shenker, A., L. Laue, S. Kosugi, J. J. Merndino, Jr., T. Minegishi, and G. B. Cutler, Jr. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature (Lond.) 365: 652-654 (1993).
35. Parma, J., L. Duprez, J. Van Sande, P. Cochaux, C. Gervy, J. Mockel, J. Dumont, and G. Vassart. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature (Lond.) 365:649-651 (1993).
36. Robbins, L. S., J. H. Nadeau, K. R. Johnson, M. A. Kelly, L. Roselli-Rehfuss, E. Baack, K. G. Mountjoy, and R. D. Cone. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 72:827-834 (1993).
37. Rothschild, K. J., Y.-W. He, D. Gray, P. D. Roepe, S. L. Pelletier, R. S. Brown, and J. Herzfeld. Fourier transform infrared evidence for proline structural changes during the bacteriorhodopsin photocycle. Proc. Natl. Acad. Sci. USA 86:9832-9835 (1989).
38. Gerwert, K, B. Hess, and M. Engelhard. Proline residues undergo structural changes during proton pumping in bacteriorhodopsin. FEBS Lett. 261:449-454 (1990).
39. Mogi, T., L. J. Stern, B. H. Chao, and H. G. Khorana. Structure-function studies on bacteriorhodopsin. VIII. Substitutions of the membrane-embedded pralines 50, 91, and 186: the effects are determined by the substituting amino acids. J. Biol. Chem. 264:14192-14196 (1989).
40. Wess, J., S. Nanavati, Z. Vogel, and R. Maggio. Functional role of proline and tryptophan residues highly conserved among G protein-coupled receptors studied by mutational analysis of the m3 muscarinic receptor. EMBO J. 12:331-338 (1993).